Application 018013

Type
NDA
Sponsor
SPECGX LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001PAMELORNORTRIPTYLINE HYDROCHLORIDECAPSULE;ORALEQ 10MG BASEYesNo
002PAMELORNORTRIPTYLINE HYDROCHLORIDECAPSULE;ORALEQ 25MG BASEYesNo
003PAMELORNORTRIPTYLINE HYDROCHLORIDECAPSULE;ORALEQ 75MG BASEYesYes
004PAMELORNORTRIPTYLINE HYDROCHLORIDECAPSULE;ORALEQ 50MG BASEYesNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N018013-001PAMELORNORTRIPTYLINE HYDROCHLORIDEEQ 10MG BASECAPSULE / ORALRLD, Approved before 1982
N018013-002PAMELORNORTRIPTYLINE HYDROCHLORIDEEQ 25MG BASECAPSULE / ORALRLD, Approved before 1982
N018013-003PAMELORNORTRIPTYLINE HYDROCHLORIDEEQ 75MG BASECAPSULE / ORALRLD, Approved before 1982
N018013-004PAMELORNORTRIPTYLINE HYDROCHLORIDEEQ 50MG BASECAPSULE / ORALRLD, Approved before 1982

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 3 of 5 · 176 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2019-12-13 00:20 UTC2019-12N018013-001PAMELOREQ 10MG BASECAPSULE / ORALABRLD, Approved before 198274a2ff9319b5…
2019-12-13 00:20 UTC2019-12N018013-002PAMELOREQ 25MG BASECAPSULE / ORALABRLD, Approved before 198274a2ff9319b5…
2019-12-13 00:20 UTC2019-12N018013-003PAMELOREQ 75MG BASECAPSULE / ORALABRLD, RS, Approved before 198274a2ff9319b5…
2019-12-13 00:20 UTC2019-12N018013-004PAMELOREQ 50MG BASECAPSULE / ORALABRLD, Approved before 198274a2ff9319b5…
2022-03-09 01:35 UTC2022-03N018013-001PAMELOREQ 10MG BASECAPSULE / ORALABRLD, Approved before 1982bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03N018013-002PAMELOREQ 25MG BASECAPSULE / ORALABRLD, Approved before 1982bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03N018013-003PAMELOREQ 75MG BASECAPSULE / ORALABRLD, RS, Approved before 1982bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03N018013-004PAMELOREQ 50MG BASECAPSULE / ORALABRLD, Approved before 1982bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N018013-001PAMELOREQ 10MG BASECAPSULE / ORALABRLD, Approved before 1982782e0a99824c…
2021-12-28 21:50 UTC2021-12N018013-002PAMELOREQ 25MG BASECAPSULE / ORALABRLD, Approved before 1982782e0a99824c…
2021-12-28 21:50 UTC2021-12N018013-003PAMELOREQ 75MG BASECAPSULE / ORALABRLD, RS, Approved before 1982782e0a99824c…
2021-12-28 21:50 UTC2021-12N018013-004PAMELOREQ 50MG BASECAPSULE / ORALABRLD, Approved before 1982782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N018013-001PAMELOREQ 10MG BASECAPSULE / ORALABRLD, Approved before 198287673890dc5c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N018013-002PAMELOREQ 25MG BASECAPSULE / ORALABRLD, Approved before 198287673890dc5c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N018013-003PAMELOREQ 75MG BASECAPSULE / ORALABRLD, RS, Approved before 198287673890dc5c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N018013-004PAMELOREQ 50MG BASECAPSULE / ORALABRLD, Approved before 198287673890dc5c…
2021-03-12 10:30 UTC2021-03N018013-001PAMELOREQ 10MG BASECAPSULE / ORALABRLD, Approved before 19825aa47cf7b7d7…
2021-03-12 10:30 UTC2021-03N018013-002PAMELOREQ 25MG BASECAPSULE / ORALABRLD, Approved before 19825aa47cf7b7d7…
2021-03-12 10:30 UTC2021-03N018013-003PAMELOREQ 75MG BASECAPSULE / ORALABRLD, RS, Approved before 19825aa47cf7b7d7…
2021-03-12 10:30 UTC2021-03N018013-004PAMELOREQ 50MG BASECAPSULE / ORALABRLD, Approved before 19825aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N018013-001PAMELOREQ 10MG BASECAPSULE / ORALABRLD, Approved before 19828869cabd3fbd…
2020-12-22 03:56 UTC2020-12N018013-002PAMELOREQ 25MG BASECAPSULE / ORALABRLD, Approved before 19828869cabd3fbd…
2020-12-22 03:56 UTC2020-12N018013-003PAMELOREQ 75MG BASECAPSULE / ORALABRLD, RS, Approved before 19828869cabd3fbd…
2020-12-22 03:56 UTC2020-12N018013-004PAMELOREQ 50MG BASECAPSULE / ORALABRLD, Approved before 19828869cabd3fbd…
2020-11-12 02:37 UTC2020-11N018013-001PAMELOREQ 10MG BASECAPSULE / ORALABRLD, Approved before 1982c0c555d07b60…
2020-11-12 02:37 UTC2020-11N018013-002PAMELOREQ 25MG BASECAPSULE / ORALABRLD, Approved before 1982c0c555d07b60…
2020-11-12 02:37 UTC2020-11N018013-003PAMELOREQ 75MG BASECAPSULE / ORALABRLD, RS, Approved before 1982c0c555d07b60…
2020-11-12 02:37 UTC2020-11N018013-004PAMELOREQ 50MG BASECAPSULE / ORALABRLD, Approved before 1982c0c555d07b60…
2019-12-14 00:12 UTC2019-12N018013-001PAMELOREQ 10MG BASECAPSULE / ORALABRLD, Approved before 19823f01610625f2…
2019-12-14 00:12 UTC2019-12N018013-002PAMELOREQ 25MG BASECAPSULE / ORALABRLD, Approved before 19823f01610625f2…
2019-12-14 00:12 UTC2019-12N018013-003PAMELOREQ 75MG BASECAPSULE / ORALABRLD, RS, Approved before 19823f01610625f2…
2019-12-14 00:12 UTC2019-12N018013-004PAMELOREQ 50MG BASECAPSULE / ORALABRLD, Approved before 19823f01610625f2…
2019-09-15 20:21 UTC2019-09N018013-001PAMELOREQ 10MG BASECAPSULE / ORALABRLD, Approved before 1982b00525d2431f…
2019-09-15 20:21 UTC2019-09N018013-002PAMELOREQ 25MG BASECAPSULE / ORALABRLD, Approved before 1982b00525d2431f…
2019-09-15 20:21 UTC2019-09N018013-003PAMELOREQ 75MG BASECAPSULE / ORALABRLD, RS, Approved before 1982b00525d2431f…
2019-09-15 20:21 UTC2019-09N018013-004PAMELOREQ 50MG BASECAPSULE / ORALABRLD, Approved before 1982b00525d2431f…
2019-07-19 19:46 UTC2019-07N018013-001PAMELOREQ 10MG BASECAPSULE / ORALABRLD, Approved before 1982ea99ee380514…
2019-07-19 19:46 UTC2019-07N018013-002PAMELOREQ 25MG BASECAPSULE / ORALABRLD, Approved before 1982ea99ee380514…
2019-07-19 19:46 UTC2019-07N018013-003PAMELOREQ 75MG BASECAPSULE / ORALABRLD, RS, Approved before 1982ea99ee380514…
2019-07-19 19:46 UTC2019-07N018013-004PAMELOREQ 50MG BASECAPSULE / ORALABRLD, Approved before 1982ea99ee380514…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 136 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N018013-001AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N018013-002AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N018013-003AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N018013-004AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N018013-001AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N018013-002AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N018013-003AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N018013-004AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N018013-001AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N018013-002AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N018013-003AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N018013-004AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N018013-001AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10N018013-002AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10N018013-003AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10N018013-004AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N018013-001AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N018013-002AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N018013-003AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N018013-004AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N018013-001AB1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N018013-002AB1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N018013-003AB1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N018013-004AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N018013-001AB11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N018013-002AB11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N018013-003AB11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N018013-004AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05N018013-001AB18072bd15b7f6…
2024-05-31 18:47 UTC2024-05N018013-002AB18072bd15b7f6…
2024-05-31 18:47 UTC2024-05N018013-003AB18072bd15b7f6…
2024-05-31 18:47 UTC2024-05N018013-004AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N018013-001AB15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N018013-002AB15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N018013-003AB15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N018013-004AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N018013-001AB15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N018013-002AB15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N018013-003AB15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N018013-004AB15d02ea3f76ae…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PAMELORNORTRIPTYLINE HYDROCHLORIDESpecGx LLCe17dc299-f52d-414d-ab6e-e809bd6f8acb2024-12-04Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 018013
application number: NDA018013
ndc (product): 0406-9912
ndc (product): 0406-9913
ndc (product): 0406-9910
ndc (product): 0406-9911

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 12 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0406-9910PAMELORnortriptyline hydrochlorideSpecGx LLCNDACurrent
0406-9910PAMELORnortriptyline hydrochlorideSpecGx LLCNDACurrent
0406-9910PAMELORnortriptyline hydrochlorideSpecGx LLCNDACurrent
0406-9911PAMELORnortriptyline hydrochlorideSpecGx LLCNDACurrent
0406-9911PAMELORnortriptyline hydrochlorideSpecGx LLCNDACurrent
0406-9911PAMELORnortriptyline hydrochlorideSpecGx LLCNDACurrent
0406-9912PAMELORnortriptyline hydrochlorideSpecGx LLCNDACurrent
0406-9912PAMELORnortriptyline hydrochlorideSpecGx LLCNDACurrent
0406-9912PAMELORnortriptyline hydrochlorideSpecGx LLCNDACurrent
0406-9913PAMELORnortriptyline hydrochlorideSpecGx LLCNDACurrent
0406-9913PAMELORnortriptyline hydrochlorideSpecGx LLCNDACurrent
0406-9913PAMELORnortriptyline hydrochlorideSpecGx LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
58276SUPPL2019-04-10
58270SUPPL2019-04-10
58269SUPPL2019-04-10
11115SUPPL2014-07-29
779SUPPL2014-07-29
13979SUPPL2014-07-11
11114SUPPL2014-07-11
13978SUPPL2012-10-29
33393SUPPL2012-10-26
23111ORIG2009-11-20
20101SUPPL2009-09-14
778SUPPL2007-07-24
33392SUPPL2007-07-16
23539ORIG2007-05-09
13977SUPPL2005-01-13
11113SUPPL2005-01-13